Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168309 · ClinicalTrials.gov registry record · NA
Oral Nifedipine Versus Oral Labetalol
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02168309 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT02168309, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study's aim is to determine whether oral extended release nifedipine is superior to oral labetolol for the management of postpartum severe hypertension, specifically time to achieve goal blood pressure, and shortening hospital stay. Our hypothesis is that oral extended release nifedipine is superior to oral labetolol for achieving goal blood pressure in the postpartum period.
Interventions
- DRUG Labetalol
- DRUG Nifedipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168309
The ClinicalTrials.gov registry entry for NCT02168309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Labetalol is the first listed.
NCT02168309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02168309 about?
NCT02168309 is a clinical study titled "Oral Nifedipine Versus Oral Labetalol". This study's aim is to determine whether oral extended release nifedipine is superior to oral labetolol for the management of postpartum severe hypertension, specifically time to achieve goal blood pressure, and shortening hospital stay. Our hypothesis is that oral extended release nifedipine is sup...
What is the current status of trial NCT02168309?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02168309?
The interventions under investigation include: Labetalol (DRUG), Nifedipine (DRUG).
Who is sponsoring clinical trial NCT02168309?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.